Moreover, PARP7 is a highly sought-after therapeutic target in cancer (Gozgit et al, 2021) and stroke (Cai et al, 2024), and deciphering the function of PARP7-mediated MARUbylation is critical for understanding its cellular function in these diseases. Here, TIPARP is linked to stroke disorder.